|
|
Allot Ltd.
By: /s/ Daniella Naveh
Daniella Naveh
Deputy General Counsel
|
| Exhibit Number |
Description
|
| 99.1 |
| 99.2 |

|
|
Sincerely,
/s/ David Reis
David Reis
Chairman of the Board of Directors
|
|
|
1. |
To approve an amendment to the Company’s Articles of Association, effective immediately upon the approval of this Proposal 1, to provide for the elimination of the different classes of members of the Board of Directors of the Company
(the “Board”), so that after completion of their current term, the term of each director who is elected or reelected at or after the Annual Meeting (other than Outside Directors (as defined in the
Israel Companies Law, 5759-1999, as amended (the “Israel Companies Law”)), shall be one year.
|
|
|
2. |
To reelect Nadav Zohar as a Class I director, to serve until the 2028 annual meeting of shareholders (or, if Proposal 1 is approved, to serve until the 2026 annual meeting of shareholders), and until his successor has been duly elected
and qualified, or until his office is vacated in accordance with the Company’s Articles of Association or the Israel Companies Law.
|
|
|
3. |
To reelect Cynthia L. Paul as a Class I director, to serve until the 2028 annual meeting of shareholders (or, if Proposal 1 is approved, to serve until the 2026 annual meeting of shareholders), and until her successor has been duly
elected and qualified, or until her office is vacated in accordance with the Company’s Articles of Association or the Israel Companies Law.
|
|
|
4. |
To reelect Steven Levy as an Outside Director of the Company, to serve for a term of three years commencing as of the Annual Meeting, or until his office is vacated in accordance with the Company’s Articles of Association or the Israel
Companies Law.
|
|
|
5. |
To approve the existing compensation policy for officers and directors of the Company (the “Compensation Policy”), as required by the Israel Companies Law, to apply for the years 2026-2028.
|
|
|
6. |
To approve an amendment to the indemnification provisions of the Company’s Articles of Association.
|
|
|
7. |
To approve an amended and restated indemnification agreement to be entered into with each of our directors.
|
|
|
8. |
To approve an amended and restated indemnification agreement to be entered into with our Chief Executive Officer.
|
|
|
9. |
To approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as Allot’s independent registered public accounting firm for the fiscal year ending December 31, 2025 and until the next annual
meeting of shareholders, and to authorize the Board, upon recommendation of the audit committee, to fix the remuneration of said independent registered public accounting firm.
|
|
|
10. |
To report on the business of the Company for the fiscal year ended December 31, 2024, including a review of the fiscal 2024 financial statements.
|
|
|
11. |
To act upon any other matters that may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
|
|
By Order of the Board of Directors,
/s/ David Reis
David Reis
Chairman of the Board of Directors
|
| Q: |
When and where is the 2025 Annual Meeting of Shareholders being held?
|
| A: |
The Annual Meeting will be held on December 15, 2025, at 2:30 p.m. Israel time, at our offices at 22 Hanagar Street, Neve Ne’eman Industrial Zone B, Hod Hasharon, Israel.
|
| Q: |
Who can attend the Annual Meeting?
|
| A: |
Any shareholder may attend. Proof of ownership of the Company’s shares as of the Record Date, as well as a form of personal photo identification, must be presented in order to be admitted to the Annual Meeting. If your shares are held
in the name of a bank, broker or other holder of record, you must bring a current brokerage statement or other proof of ownership with you to the Annual Meeting.
|
| Q: |
Who is entitled to vote?
|
| A: |
Only holders of record of ordinary shares at the close of business on October 29, 2025, the Record Date for the Annual Meeting, are entitled to vote at the Annual Meeting.
|
| Q: |
How do I vote?
|
| A: |
You may vote by mail. You can do this by completing your proxy card (if you are a shareholder of record) or your voting instruction card (if you are a “street name” beneficial owner) and
returning it in the enclosed, prepaid and addressed envelope. If you return a signed card but do not provide voting instructions, your shares will be voted as recommended by the Board.
|
| Q: |
What is the difference between holding shares as a shareholder of record and holding shares in “street name”?
|
| A: |
Many Allot shareholders hold their shares through a bank, broker or other nominee rather than directly in their own name. As explained in this proxy statement, there are some distinctions between shares held of record and shares owned
in “street name.”
|
| Q: |
Does Allot recommend I vote in advance of the Annual Meeting?
|
| A: |
Yes. Even if you plan to attend the Annual Meeting, Allot recommends that you vote your shares in advance so that your vote will be counted if you later decide not to attend the Annual Meeting.
|
| Q: |
If I vote by proxy, can I change my vote or revoke my proxy?
|
| A: |
Yes. You may change your proxy instructions at any time prior to the vote at the Annual Meeting. If you are a shareholder of record, you may do this by:
|
|
|
• |
filing a written notice of revocation with the Secretary of the Company, delivered to the Company’s address above;
|
|
|
• |
granting a new proxy card bearing a later date; or
|
|
|
• |
attending the Annual Meeting and voting in person (attendance at the Annual Meeting will not cause your previously granted proxy to be revoked unless you submit another vote at the Annual Meeting).
|
| Q: |
How are my votes cast when I submit a proxy vote?
|
| A: |
When you submit a proxy vote, you appoint Liat Nahum and Rael Kolevsohn, or either of them, as your representative(s) at the Annual Meeting. Your shares will be voted at the Annual Meeting as you have instructed.
|
| Q: |
What does it mean if I receive more than one proxy card?
|
| A: |
It means that you have multiple accounts at the transfer agent or with brokers. Please sign and return all proxy cards to ensure that all of your shares are voted.
|
| Q: |
What constitutes a quorum?
|
| A: |
To conduct business at the Annual Meeting, two or more shareholders must be present, in person or by proxy, representing not less than 25% of the ordinary shares outstanding as of the Record Date, that is, a quorum must be present.
|
| Q: |
What happens if a quorum is not present?
|
| A: |
If a quorum is not present, the Annual Meeting will be adjourned to the same day at the same time the following week, or to such day and at such time and place as the Chairperson of the Annual Meeting may determine with the consent of
the holders of a majority of the shares present in person or by proxy and voting on the question of adjournment.
|
| Q: |
How will votes be counted?
|
| A: |
Each outstanding ordinary share is entitled to one vote. The Company’s Articles of Association do not provide for cumulative voting.
|
| Q: |
What vote is required to approve each proposal presented at the Annual Meeting?
|
| A: |
Proposal 1 (approval of an amendment to our Articles of Association to provide for the elimination of the different classes of members of the Board of Directors of the Company) requires that securities representing at least two-thirds
of the voting securities of the Company then outstanding be voted “FOR” the adoption of the proposal.
|
| Q: |
How will my shares be voted if I do not provide instructions on the proxy card?
|
| A: |
If you are the record holder of your shares and do not specify on your proxy card how you want to vote your shares, your shares will be voted in favor of the proposals in accordance with the recommendation of the Board:
|
|
|
1. |
“FOR” the approval of an amendment to the Company’s Articles of Association, effective immediately upon the approval of Proposal 1, to provide for the elimination of the different classes of
members of the Board and to set the term of each director who is elected or reelected at or after the Annual Meeting (other than Outside Directors, who shall continue to serve in accordance with the Israel Companies Law) to one year.
|
|
|
2. |
“FOR” the reelection of Nadav Zohar as a Class I director, to serve until the 2028 annual meeting of shareholders (or, if Proposal 1 is approved, to serve until the 2026 annual meeting of
shareholders), and until his successor has been duly elected and qualified, or until his office is vacated in accordance with the Company’s Articles of Association or the Israel Companies Law.
|
|
|
3. |
“FOR” the reelection of Cynthia L. Paul as a Class I director, to serve until the 2028 annual meeting of shareholders (or, if Proposal 1 is approved, to serve until the 2026 annual meeting of
shareholders), and until her successor has been duly elected and qualified, or until her office is vacated in accordance with the Company’s Articles of Association or the Israel Companies Law.
|
|
|
4. |
“FOR” the reelection of Steven Levy as an Outside Director of the Company, to serve for a term of three years commencing as of the Annual Meeting, or until his office is vacated in accordance
with the Company’s Articles of Association or the Israel Companies Law.
|
|
|
5. |
“FOR” the approval of the Compensation Policy for the years 2026-2028.
|
|
|
6. |
“FOR” the approval of the amendment of the indemnification provisions of the Company’s Articles of Association.
|
|
|
7. |
“FOR” the approval of an amended and restated indemnification agreement to be entered into with each of our directors.
|
|
|
8. |
“FOR” the approval of an amended and restated indemnification agreement to be entered into with our Chief Executive Officer.
|
|
|
9. |
“FOR” the approval of the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as Allot’s independent registered public accounting firm for the fiscal year
ending December 31, 2025 and until the next annual meeting of shareholders, and to authorize the Board, upon recommendation of the audit committee, to fix the remuneration of said independent registered public accounting firm.
|
|
|
10. |
In accordance with the best judgment of the named proxies on any other matters properly brought before the annual meeting and any postponement(s) or adjournment(s) thereof.
|
| Q: |
Where do I find the voting results of the Annual Meeting?
|
| A: |
We plan to announce preliminary voting results at the Annual Meeting and to report the final voting results following the Annual Meeting in a Report of Foreign Private Issuer on Form 6-K that we will furnish to the SEC.
|
| Q: |
Who will bear the costs of solicitation of proxies for the Annual Meeting?
|
| A: |
The Company will bear the costs of solicitation of proxies for the Annual Meeting. In addition to solicitation by mail, directors, officers and employees of the Company may solicit proxies from shareholders by telephone, personal
interview or otherwise. Such directors, officers and employees will not receive additional compensation, but may be reimbursed for reasonable out-of-pocket expenses in connection with such solicitation. Brokers, nominees, fiduciaries and
other custodians have been requested to forward soliciting material to the beneficial owners of ordinary shares held of record by them, and such custodians will be reimbursed by the Company for their reasonable out-of-pocket expenses. The
Company may also retain an independent advisor to assist in the solicitation of proxies. If retained for such services, the costs will be paid by the Company.
|
|
|
Ordinary Shares
Beneficially
Owned (1)
|
Percentage of
Ordinary Shares
Beneficially
Owned
|
||||||
|
Lynrock Lake Master Fund LP (2)
|
10,043,295
|
20.7
|
%
|
|||||
|
QVT Financial LP (3)
|
3,555,793
|
7.3
|
%
|
|||||
|
Kanen Wealth Management, LLC (4)
|
4,163,573
|
8.6
|
%
|
|||||
|
|
(1) |
As used in this table, “beneficial ownership” means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security. For purposes of this table, a person is deemed to be the beneficial
owner of ordinary shares that can be acquired within 60 days from the Record Date through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days
are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based
upon 48,425,616 ordinary shares outstanding as of the Record Date.
|
|
|
(2) |
Based on information from the Company, Lynrock Lake Partners LLC directly holds 10,011,295 of our ordinary shares and Cynthia L. Paul directly holds 32,000 of our ordinary shares. Ms. Paul, the Chief Investment Officer of Lynrock Lake
LP (“Lynrock Lake”) and Sole Member of Lynrock Lake Partners LLC, the general partner of Lynrock Lake, exercises voting and investment power over securities of the Issuer held by Lynrock Lake Master Fund LP. The business address of such
holders is 2 International Drive, Suite 130, Rye Brook, NY 10573.
|
|
|
(3) |
Based on a Schedule 13D/A filed on February 28, 2025, QVT Family Office Fund LP (“QVT Fund”) had shared voting and dispositive power over 3,555,793 of our ordinary shares. QVT Financial LP (“QVT Financial”), as the investment manager
for QVT Fund, and QVT Associates GP LLC (“QVT Fund GP”), was the general partner of the QVT Fund, have voting and dispositive power over these shares. The principal executive offices of QVT Fund, QVT Financial and QVT Fund GP is 888
Seventh Avenue, 43rd Floor, New York, New York 10106.
|
|
|
(4) |
Based on a Schedule 13G/A filed on June 12, 2025 by Philotimo Fund LP, a Delaware limited partnership (“Philotimo”), Philotimo Focused Growth and Income Fund, a series of World Funds Trust and a Delaware statutory trust (“PHLOX”),
Kanen Wealth Management, LLC, a Florida limited liability company (“KWM”) and David L. Kanen, Philotomo beneficially owned 2,325,000 of our ordinary shares, PHLOX beneficially owned 1,200,000 of our ordinary shares, and KWM and David L.
Kanen had each shared voting and dispositive power over 4,103,882 of our ordinary shares and David L. Kannen directly held 59,691 of our ordinary shares. David L. Kanen is the managing member of KWM and has voting and dispositive power
over these shares. The business address of such holders is 6810 Lyons Technology Circle, Suite 160, Coconut Creek, Florida 33073.
|
|
Name
|
Ordinary Shares Beneficially
Owned(1)
|
Percentage of Ordinary
Shares Beneficially
Owned
|
||
|
Directors
|
||||
|
David Reis
|
*
|
*
|
||
|
Raffi Kesten
|
*
|
*
|
||
|
Nadav Zohar
|
*
|
*
|
||
|
Cynthia L. Paul(2)
|
10,043,295
|
20.7%
|
||
|
Efrat Makov
|
*
|
*
|
||
|
Steven D. Levy
|
*
|
*
|
||
|
Executive Officers
|
||||
|
Eyal Harari
|
*
|
*
|
||
|
Liat Nahum
|
*
|
*
|
||
|
Rael Kolevsohn
|
*
|
*
|
||
|
Mark Shteiman
|
*
|
*
|
||
|
Gili Groner
|
*
|
*
|
||
|
Boaz Grossman
|
*
|
*
|
||
|
Noam Lila
|
*
|
*
|
||
|
All directors, director nominees and executive officers as a group
|
11,082,354
|
22.9%
|
|
|
39.2.1 |
Commencing with the Company’s 2025 Annual General Meeting, the members of the Board of Directors of the Company, other than Outside Directors, shall be elected by an Ordinary Resolution in a General Meeting, and each such Director
shall hold office until the next Annual General Meeting and until his or her successor shall be elected and qualified.
|
|
|
39.2.2 |
Notwithstanding the foregoing Article 39.2.1, any Director, other than Outside Directors, elected prior to the Company’s 2025 Annual General Meeting shall hold office until the completion of his or her then-current term of office.
|
|
|
|
|
”
|
|
|
1. |
a simple majority of shares voted at the Annual Meeting, excluding the shares of controlling shareholders and of shareholders who have a personal interest in the approval of the resolution,
other than a personal interest in the appointment that is not as a result of relationship with the controlling shareholder, be voted “FOR” the resolution; or
|
|
|
2. |
the total number of shares of non-controlling shareholders and of shareholders who do not have a personal interest in the approval of the resolution voted against approval of the resolution does not exceed two percent of the
outstanding voting power in the Company.
|
|
|
1. |
a simple majority of shares voted at the Annual Meeting, excluding the shares of controlling shareholders and of shareholders who have a personal interest in the approval of the resolution, be
voted “FOR” the resolution; or
|
|
|
2. |
the total number of shares of non-controlling shareholders and of shareholders who do not have a personal interest in the approval of the resolution voted against approval of the resolution does not exceed two percent of the
outstanding voting power in the Company.
|
|
|
62.1.1 |
a breach of duty of care to the Company or to any other person;
|
|
|
62.1.2 |
a breach of his or her duty of loyalty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds to assume that act that resulted in such breach would not prejudice the interests of the Company;
|
|
|
62.1.3 |
a financial liability imposed on such Office Holder in favor of any other person; and
|
|
|
62.1.4 |
any other event, occurrence, matters or circumstances under any law with respect to which the Company may, or will be able to, insure an Office Holder, and to the extent such law requires the inclusion of a provision permitting such
insurance in these Articles, then such provision is deemed to be included and incorporated herein by reference (including in accordance with Section 56h(b)(1) of the Securities Law, 5728-1968 if and to the extent applicable, and Section
50P of the Economic Competition Law, 5748-1988).
|
|
|
62.2.1 |
The Company may retroactively indemnify an Office Holder to the maximum extent permitted under applicable law, including with respect to the following liabilities and expenses, provided that
such liabilities or expenses were imposed on such Office Holder or incurred by such Office Holder due to an act performed by or an omission of the Office Holder in such Office Holder’s capacity as an Office Holder:
|
|
|
62.2.1.1 |
a financial liability imposed on an Office Holder in favor of another person by any court judgment, including a judgment given as a result of a settlement or an arbitrator’s award which has been confirmed by a court;
|
|
|
62.2.1.2 |
reasonable litigation expenses, including reasonable legal fees, expended by the Office Holder as a result of an
investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, or in connection with a financial sanction, provided that (1) no indictment (as defined in the Companies Law) was filed against such Office Holder as a result of such investigation or proceeding; and (2) no financial
liability in lieu of a criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding or if such financial liability was imposed, it was imposed with respect to an
offense that does not require proof of criminal intent;
|
|
|
62.2.1.3 |
reasonable litigation costs, including reasonable legal fees, expended by an Office Holder or which were imposed on an Office Holder by a court in proceedings filed against the Office Holder by the Company or in its name or by any
other person or in a criminal charge in respect of which the Office Holder was acquitted or in a criminal charge in respect of which the Office Holder was convicted for an offence which did not require proof of criminal intent; and
|
|
|
62.2.1.4 |
any other event, occurrence, matter or circumstance under any law with respect to which the Company may, or will be able to, indemnify an Office Holder, and to the extent such law requires the inclusion of a provision permitting such
indemnity in these Articles, then such provision is deemed to be included and incorporated herein by reference (including in accordance with Section 56H(b)(1) of the Securities Law, 5728-1968 if and to the extent applicable, and Section
50P(b)(2) of the Economic Competition Law, 5748-1988).
|
|
|
62.2.2 |
The Company may undertake to indemnify an Office Holder, in advance, with respect to those liabilities and expenses described in the following Articles:
|
|
|
62.2.2.1 |
Sub-Article 0, provided that the undertaking to indemnify is limited to, and sets forth, (a) such events which the Directors shall deem to be foreseeable in light of the operations of the Company at the
time that the undertaking to indemnify is made, and (b) such amounts or criteria which the Directors may, at the time of the giving of such undertaking to indemnify, deem to be reasonable under the circumstances; and
|
|
|
62.2.2.2 |
Sub-Articles 0, 0 and 0
|
|
|
62.4.1 |
Any amendment to the Companies Law or any other applicable law adversely affecting the right of any Office Holder to be indemnified, insured or exempt pursuant to this Article 62 and any amendments to this Article 62 shall be
prospective in effect, and shall not affect the Company’s obligation or ability to indemnify, insure or exculpate an Office Holder for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law.
|
|
|
62.4.2 |
The provisions of this Article 62: (i) shall apply to the maximum extent permitted by law (including the Companies Law, the Securities Law, 5728-1968 and the Economic Competition Law, 5748-1988); and (ii) are not intended, and shall
not be interpreted so as to restrict the Company, in any manner, in respect of the procurement of insurance or in respect of indemnification (whether in advance or retroactively) or exculpation in favor of any person who is not an Office
Holder, including any employee, agent, consultant or contractor of the Company who is not an Office Holder; or any Office Holder to the extent that such insurance or indemnification is not specifically prohibited.”
|
|
|
1. |
a simple majority of shares voted at the Annual Meeting, excluding the shares of controlling shareholders and of shareholders who have a personal interest in the approval of the resolution, be voted “FOR” the resolution; or
|
|
|
2. |
the total number of shares of non-controlling shareholders and of shareholders who do not have a personal interest in the approval of the resolution voted against approval of the resolution does not exceed two percent of the
outstanding voting power in the Company.
|
|
Year ended December 31,
|
||||||||
|
2023
|
2024
|
|||||||
|
(in thousands of U.S. dollars)
|
||||||||
|
Audit Fees (1)
|
489
|
480
|
||||||
|
Audit-Related Fees (2)
|
5
|
7
|
||||||
|
Tax Fees (3)
|
70
|
49
|
||||||
|
Other
|
-
|
|||||||
|
Total
|
564
|
536
|
||||||
| (1) |
“Audit fees” include fees for services performed by the Company’s independent public accounting firm in connection with our annual audit for 2023 and 2024, certain procedures regarding the Company’s quarterly financial results
submitted on Form 6-K and consultation concerning financial accounting and reporting standards.
|
| (2) |
“Audit-Related fees” relate to assurance and associated services that are traditionally performed by the independent auditor, including: accounting consultation and consultation concerning financial accounting, reporting standards and
due diligence investigations.
|
| (3) |
“Tax fees” include fees for professional services rendered by our independent registered public accounting firm for tax compliance, transfer pricing and tax advice on actual or contemplated transactions.
|
|
|
By Order of the Board of Directors,
/s/ David Reis David Reis
Chairman of the Board of Directors
|
| 1. |
Preamble
|
| 2. |
Compensation policy goals
|
|
|
2.1 |
Pay for performance
|
|
|
• |
To closely align the interests of the Executive Officers with those of Allot’s stockholders in order to enhance stockholder value;
|
|
|
• |
To offer a collaborative workplace environment where each Executive Officer has the opportunity to impact Allot’s long-term success;
|
|
|
• |
To provide increased rewards for superior individual and corporate performance, and substantially reduced or no rewards for average or inadequate performance.
|
|
|
2.2 |
Risk management
|
|
|
• |
To ensure that while a significant portion of each Executive Officer’s total compensation is at risk and tied to the achievement of financial, corporate, functional performance and other goals established by the Board of Directors,
overall risk taking is managed and maintained;
|
|
|
• |
To minimize any personal incentives for taking high-risks that might potentially imperil the underlying value of Allot.
|
| 3. |
Compensation elements
|
|
|
• |
Base salary;
|
|
|
• |
Benefits and perquisites;
|
|
|
• |
Cash bonus;
|
|
|
• |
Equity compensation;
|
|
|
• |
Retirement and termination of service arrangements.
|
| 4. |
Base Salary (or Fee)
|
|
|
• |
Companies that compete with the company for executive talent;
|
|
|
• |
Companies that are direct competitors of the company;
|
|
|
• |
Companies with a similar revenue turnover as that of the Company;
|
|
|
• |
Companies with a similar market cap as that of the Company;
|
|
|
• |
Geographical considerations.
|
| 5. |
Benefits and perquisites
|
|
|
5.1 |
Benefits and perquisites which are required or facilitated under local laws or customary in the relevant jurisdiction may include, inter alia, the following:
|
|
|
• |
Vacation of up to 25 days per annum;
|
|
|
• |
Sick days of up to 18 days per annum (or as required by law);
|
|
|
• |
Annual convalescence pay as required by law;
|
|
|
• |
Payments to pension funds or other types of pension schemes (e.g. managers’ insurance programs);
|
|
|
• |
Disability Insurance;
|
|
|
• |
Payments to an Advanced Study fund as afforded by law;
|
|
|
• |
Housing (in relevant markets);
|
|
|
• |
Health coverage plans and medical expenses.
|
|
|
5.2 |
Additional benefits intend to complement cash compensation and offer non-monetary rewards to the Executive Officers, and may include, inter alia, the following benefits:
|
|
|
• |
Company cellular phone and related expenses;
|
|
|
• |
Communication equipment and related expenses;
|
|
|
• |
Travel and or car allowance and or Company car and related expenses;
|
|
|
• |
Education allowances;
|
|
|
• |
Subscriptions to relevant literature.
|
|
|
• |
Memberships in statutory and professional organizations
|
| 6. |
Retirement and termination of service arrangements
|
|
|
• |
Advance notice - advance notice upon termination of employment for a certain period of time, which in any case will not exceed a term of 6 months. During
such period of time, the Executive Officer may be required to continue his active employment with Allot.
|
|
|
• |
Severance pay - all Israeli Executive Officers are subject to the provisions of Section 14 of the Israeli Severance Pay Law. Accordingly, Allot will disburse
an amount equivalent to 8.33% of the monthly salary (or any other amount required by applicable law) towards severance pay liability in lieu of paying the full amount of severance pay upon termination of employment.
|
|
|
• |
Transition period – Executive Officers may receive up to 6 months of base salary and benefits (i.e., excluding bonuses and equity based compensation), taking into account the period of service or employment of the Executive Officer, his/her service and employment conditions in the course of such period, Allot’s performance during such period, the contribution of the Executive Officer to the achievement of Allot’s targets and profits and the circumstances of the termination of employment. The
Executive Officer may not be required to continue his active employment with Allot during this period.
|
|
|
• |
Health insurance for US or other Executive Officers - payment for up to 6 months of post-termination health insurance upon termination of employment.
|
| 7. |
Cash Bonuses
|
|
|
7.1 |
CEO
|
|
|
7.1.1 |
The payout formula for the CEO of Allot is designed to drive performance and motivation of the CEO, while maintaining a firm risk management mechanism.
|
|
|
7.1.2 |
The payout formula will include the following types of measures that will be calculated separately:
|
|
|
(i) |
Company Performance Measures (financial and operational): Such as revenues, operating income, booking, income before tax and interest (may be set on GAAP or Non- GAAP basis, according to the discretion of the Board of Directors), etc,
measured against the targets of the annual budget of the Company for the relevant year (the "Targets"). The weight of Company performance will constitute at least 70% of the annual target bonus (i.e.
bonus for 100% achievement of Targets).
|
|
|
(ii) |
Individual Performance Measures: These measures will be defined at the beginning of each fiscal year by the Compensation Committee and Board of Directors and may include quantitative measures and/or qualitative measures that are
measurable. The weight of these individual performance measures will constitute the balance of the annual target bonus.
|
|
|
7.1.3 |
Discretionary component - Based on evaluation of the CEO's performance and contribution to the Company’s success, the Compensation Committee and Board of Directors may grant the CEO with an additional amount of up to 3 monthly base
salaries of the CEO. In any event, the total annual bonus for the CEO will not exceed the maximum bonus opportunity set forth in Section 7.3 below.
|
|
|
7.2 |
Executive Officers Reporting to the CEO
|
|
|
7.2.1 |
For Executive Officers reporting to the CEO, the payout formula will be similar to the payout formula described above for the CEO, with the weight of Company performance measures constituting at least 50% of the target bonus and the
remainder will constitute individual performance measures and/or evaluation of performance at the discretion of the Compensation Committee and the Board of Directors.
|
|
|
7.2.2 |
Notwithstanding the aforesaid, the Compensation Committee and the Board of Directors will have full discretion to determine the actual bonus payout and increase the actual bonus payout based, among other things, on additional
considerations relevant to the performance and objectives of the Company and the relevant Executive Officer, including non-measurable criteria. In any event, the total annual bonus will not exceed the maximum bonus opportunity set forth in
Section 7.3 below.
|
|
|
7.3 |
Maximum bonus opportunity
|
|
|
7.3.1 |
The annual cash bonus of the CEO shall not exceed in any given year 150% of the CEO’s annual base salary.
|
|
|
7.3.2 |
The annual cash bonus of any other Executive Officer shall not exceed in any given year 100% of the Executive Officer’s annual base salary.
|
|
|
7.4 |
Incentive Plan to sales and marketing Executive Officers
|
|
|
7.4.1 |
The overall compensation of the sales Executive Officers is specifically designed to motivate their performance. Therefore, the variable element of their compensation (with an emphasis on sales commissions they receive, as will be
defined below) is relatively larger when compared to the variable element of other Executive Officers’ compensation, whereas the fixed element of their compensation is smaller.
|
|
|
7.4.2 |
The annual sales incentive plan for each sales and marketing Executive Officer shall be determined as follows:
|
|
|
• |
Executive officer’s targets will be set at the beginning of each year (the “Sales Targets”). Achieving up to 100% of Sales Targets may correspond to up to 100% of the annual base salary of the
Executive Officer.
|
|
|
• |
The annual sales incentive payable to sales and marketing Executive Officers is capped at 250% of their annual base salary.
|
|
|
• |
Notwithstanding the aforesaid, the Compensation Committee and the BOD will have full discretion to determine the sales incentives or other bonus payout and to increase the actual sales incentives or other bonus payout based, among others
things, on additional considerations relevant to the performance and objectives of the Company and the relevant Executive Officer, including non-measurable criteria. In any event, the total annual sales incentives and bonuses will not
exceed the cap stated in this Section 7.4.2 above.
|
|
|
7.5 |
Adjustment of Targets and Goals
|
|
|
7.6 |
Bonus for an extraordinary transaction or effort
|
|
|
7.7 |
Change of control retention grant
|
|
|
7.8 |
Payout in cash or equity based compensation
|
|
|
7.9 |
Partial bonus payout
|
| 8. |
Equity-based awards
|
|
|
8.1 |
Executive Officers’ equity-based awards
|
|
|
• |
Equity-based awards may be granted upon recruitment of an executive officer or from time to time, and while taking into consideration, inter alia, the educational background, prior business experiences, aptitude, qualifications, role,
and personal responsibilities of the Executive Officer.
|
|
|
• |
The equity-based awards which may be granted to an Executive Officer, will not exceed in value (based on accepted valuation methods), on the date of grant, per vesting annum, the following amounts:
|
|
|
o |
CEO – $1,000,000;
|
|
|
o |
Chairman – $500,000;
|
|
|
o |
Other Executive Officers – $500,000.
|
|
|
• |
The Compensation Committee and the Board of Directors also considered setting a cap on value for equity based compensation at the time of exercise and concluded that this would not be advisable for Allot.
|
|
|
• |
Such equity-based awards shall vest over a minimum period of 2 to 4 years.
|
|
|
• |
The equity-based awards will expire within 10 years as of their grant date.
|
|
|
8.2 |
Acceleration of equity-based awards
|
| 9. |
Overall compensation - Ratio between fixed and variable compensation
|
| 10. |
Internal Compensation Ratio
|
| 1 |
As of the date of this policy, the ratio between the CEO compensation and the average compensation of the other employees is 6.4; the ratio between the CEO compensation and the median compensation of the other employees is 7.1; the ratio
between the average compensation of other Executive Officers and the average compensation of the other employees is 2.9; and the ratio between the average compensation of other Executive Officers and the median compensation of the other
employees is 3.3.
|
| 11. |
Compensation of members of Allot’s Board of Directors
|
|
|
11.1 |
Compensation of the members of Allots Board which are non-executive directors
|
|
|
• |
The non-executive members of Allot’s Board of Directors may (and, in the case of outside directors, shall) be entitled to remuneration and refund of expenses according to the provisions of the Companies Regulations (Rules on
Remuneration and Expenses of Outside Directors), 5760-2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel), 5760-2000, as such regulations may be amended from time to time.
|
|
|
• |
In addition, the non-executive members of Allot’s Board of Directors may be eligible to participate in Allot’s equity plans. Such equity grants will vest over a period of not less than one year, to be determined by Allot’s Board of
Directors with respect to each grant, and will not exceed in value (based on accepted valuation methods), on the date of grant, $200,000, per vesting annum. The non-executive members of Allot’s Board of Directors may also receive equity
grants with immediate vesting, but such grants will be treated as cash compensation for purposes of this Compensation Policy.
|
|
|
11.2 |
Acceleration of equity-based awards
|
|
|
11.3 |
Compensation of the Chairman
|
|
|
• |
The Chairman of Allot’s Board of Directors may be entitled to monthly or annual fees as provided in Section 4 above and to benefits and perquisites as provided in Section 5. In the event that the services of the Chairman are provided via
a personal management company and not by the Chairman directly as an employee of Allot, the fees paid to such personal management company shall reflect, to the extent determined by Allot in the applicable service agreement, the base salary
and the benefits and perquisites (plus applicable Value Added Tax), in accordance with the guidelines of the Compensation Policy.
|
|
|
• |
The Chairman of Allot’s Board of Directors may be eligible to participate in Allot’s equity plans and the provisions of Section 8 regarding the equity-based awards may apply. Such equity-based awards shall not exceed in value (based on
accepted valuation methods), on the date of grant, $500,000 per vesting annum. The equity-based awards shall vest over a period of between 2 – 4 years.
|
| 12. |
Exculpation, indemnification and insurance of Executive Officers
|
|
|
12.1 |
Exculpation
|
|
|
12.2 |
Indemnification
|
|
|
12.3 |
Insurance
|
| 13. |
Board discretion to reduce compensation elements
|
| 14. |
Compensation recovery (Claw-back)
|
|
|
a. |
Financial liability imposed on you in favor of any person pursuant to a judgment, including a judgment rendered in the context of a settlement or an arbitration award confirmed by a court. For purposes of Section 1 of this Undertaking,
the term “person” shall include a natural person, firm, partnership, joint venture, trust, company, corporation, limited liability entity, unincorporated organization, estate, government, municipality, or any political, governmental,
regulatory or similar agency or body.
|
|
|
b. |
Reasonable litigation expenses, including attorneys’ fees, incurred by you as a result of an investigation or any proceeding instituted against you by an authority that is authorized to conduct an investigation or proceeding, and that
was concluded without the filing of an indictment against you in a matter in which a criminal investigation has been instigated and without there being imposed on you a financial obligation in lieu of a criminal proceeding, or that was
concluded without the filing of an indictment against you in a matter in which a criminal investigation has been instigated but with the imposition of a financial obligation in lieu of a criminal proceeding with respect to an offense that
does not require proof of mens rea, or in connection with a financial sanction. In this paragraph:
|
|
|
i. |
“conclusion of a proceeding without the filing of an indictment in a matter in which a criminal investigation has been instigated” – shall have the meaning
specified in Section 260(a)(1A) of the Companies Law;
|
|
|
ii. |
“financial obligation in lieu of a criminal proceeding” – a financial liability imposed by applicable law in lieu of a criminal proceeding, including an administrative fine under the Administrative Offenses Law, 5746-1985, a fine for an
offense categorized as a fine-bearing offense under the provisions of the Criminal Procedure Law, a financial sanction or a penalty;
|
|
|
c. |
Reasonable litigation expenses, including attorneys’ fees, incurred by you, or assessed against you by a court, in a proceeding instituted against you by Allot or on its behalf or by another person, or in a criminal charge from which you
are acquitted or in which you are convicted of an offense that does not require proof of mens rea.
|
|
|
d. |
Expenses incurred by you in connection with a proceeding pursuant to Article D of Chapter Four of Part Nine of the Companies Law, as amended from time to time, including reasonable litigation expenses, and including attorneys’ fees.
|
|
|
e. |
Expenses incurred by you in connection with a proceeding under the Israeli Economic Competition Law, 5748-1988, which is conducted with respect to you, including reasonable litigation expenses, and including attorneys’ fees.
|
|
|
f. |
Any other liability or other expense for which it is permitted or will be permitted by applicable law to indemnify you, including in accordance with Section 56h(b)(1) of the Israeli Securities Law, 5728-1968.
|
|
|
a. |
breach of the duty of loyalty, unless you acted in good faith and had a reasonable basis to assume that such action would not prejudice the best interests of Allot;
|
|
|
b. |
intentional or reckless breach of the duty of care, but specifically excluding negligence;
|
|
|
c. |
an action taken with the intention to unlawfully gain personal profit; or
|
|
|
d. |
any fine, civil fine, financial sanction or penalty imposed on you.
|
|
|
a. |
The maximum aggregate amount of indemnification to be paid by Allot to all Office Holders who are entitled to indemnification, whether in advance or retroactively, according to all the indemnification undertakings that Allot has granted
or may grant from time to time to its Office Holders (including indemnification undertakings granted to Office Holders of its direct and indirect subsidiaries), if and to the extent it will grant the same, shall not exceed, in the
aggregate, the greatest of (i) 25% of Allot’s total shareholders’ equity (as reported in Allot’s last published consolidated financial statements prior to the event giving rise to the indemnification), (ii) US$ 200,000,000, (iii) 10% of the
total market capitalization of Allot (calculated as (x) the average closing price on the Nasdaq Stock Exchange of Allot’s ordinary shares over the 30 trading days prior to the date of the event giving rise to the indemnification, multiplied
by (y) the total number of issued and outstanding shares of Allot as of the date of each payment), and (iv) in connection with or arising out of a public offering of Allot’s securities, the aggregate gross amount of proceeds from the sale
of, or value exchanged in relation to, such securities by Allot and, if applicable, any selling shareholder in such offering (the “Maximum Indemnification Amount”).-
|
|
|
b. |
If the total of the amounts for which all Office Holders are entitled to indemnification exceeds the Maximum Indemnification Amount, each relevant Office Holder, including you, will receive indemnification based on the ratio between the
amount for which such Office Holder is liable and the aggregate amount for which all Office Holders are liable with respect to such matter.
|
|
|
c. |
In the event that you receive indemnification from an insurer in accordance with a directors and officers insurance policy with respect to a matter that is the subject of indemnification, the indemnification shall be granted in the
amount of the difference between the indemnification due to the Office Holder according to this Undertaking for such indemnification, and the amount received from the insurer in respect of such matter, provided that the indemnification
amount to which Allot has committed does not exceed the Maximum Indemnification Amount. In the event that you receive indemnification from the insurer as stated, Allot’s liability shall not be reduced according to this Undertaking and the
amounts of the total indemnification may be beyond the amounts received from the insurance company up to the Maximum Indemnification Amount.
|
|
|
a. |
You shall notify Allot of any judicial or administrative proceeding (“Legal Proceeding”) that may be initiated against you, and of any suspicion or threat that any such Legal Proceeding may be
initiated against you, promptly after you first become aware of it, and you shall forward to Allot or to whomever is designated by Allot, without delay, any document you receive in connection with such proceeding. The failure to so notify
Allot shall not relieve Allot of any obligation which it may have to the you under this Undertaking, or otherwise, unless and only to the extent that such failure or delay materially prejudices Allot.
|
|
|
b. |
Allot shall be entitled to assume your legal defense in such Legal Proceeding or to turn over such defense to any counsel selected by Allot for this purpose and reasonably acceptable to you.
|
|
|
c. |
Allot or such counsel shall be exclusively entitled to conduct your legal defense and to conclude such proceeding as they deem fit. At the request of Allot, you shall sign any document authorizing Allot or such counsel to handle your
defense in such proceeding and to represent you in all matters related thereto, in accordance with the above. Allot shall not be liable to indemnify you under this Undertaking for any amounts or expenses paid in connection with a settlement
of any action, claim or otherwise, effected by you without Allot’s prior written consent (not to be unreasonably withheld).
|
|
|
d. |
If Allot acts in accordance with the provisions of subsection (c) above and you enable it to do so, Allot will cover all the other expenses and payments that are involved so that you will not be required to pay or finance them yourself,
without this detracting from the indemnification to which you are entitled pursuant to this Undertaking.
|
|
|
e. |
You shall fully cooperate with Allot or any such counsel as may be required of you by any of them as part of their dealing with such Legal Proceeding, provided that Allot will cover all expenses involved so that you will not be required
to pay or finance them yourself.
|
|
|
Sincerely,
Allot Ltd.
By:
Name: Title: |
|
I hereby agree to the conditions of the above
Indemnification Undertaking:
By: ___________________________________
Name:
|
| a. |
actions or omissions deriving from Allot being public or traded on a stock exchange, or relating to an offer to the public or the public or private issuance of securities of Allot by Allot or by a shareholder, whether such liabilities
and expenses relate to the securities laws of the United States, of Israel or of any other jurisdiction;
|
| b. |
any claims that matters that were required to be included in public disclosures were not disclosed as required by applicable law, whether such liabilities and expenses relate to the securities laws of the United States, of Israel or of
any other jurisdiction;
|
| c. |
actions or omissions in a Corporate Capacity relating to the operations and management of Allot;
|
| d. |
actions or omissions in connection with investments Allot makes in other entities, whether before or after the investment is made, for the purpose of entering into, effecting, developing, monitoring and supervising the transaction;
|
| e. |
actions or omissions relating to the purchase or sale of companies, legal entities or their assets, their splitting or merging;
|
| f. |
any sale, purchase or holding of marketable securities, or other investments for or on behalf of Allot;
|
| g. |
actions or omissions relating to patents, trademarks, copyrights and other intellectual property of Allot, including their protection, including by registration or assertion of rights to intellectual property and the defense of claims
relating thereof;
|
| h. |
actions or omissions relating to Allot’s labor relations or Allot’s commercial relationships, including with employees, independent contractors, customers, suppliers and other service providers;
|
| i. |
any “Transaction” as defined in Section 1 of the Companies Law;
|
| j. |
actions or omissions relating to the distribution of dividends or repurchase of shares or returns of capital or loans of Allot;
|
| k. |
actions or omissions relating to tender offers, including actions relating to delivery of opinions in relation thereto, of Allot;
|
| l. |
actions or omissions relating to a merger or restructuring of Allot, including events in connection with change in ownership or in the structure of Allot, its reorganization, dissolution, winding up, any other arrangements concerning
creditors rights or any decision concerning any of the foregoing, including but not limited to, merger, sale or acquisition of assets, division, spin off, divestiture, change in capital;
|
| m. |
actions or omissions relating to environmental matters;
|
| n. |
actions or omissions in connection with any restrictive trade practice or monopolies of Allot;
|
| o. |
actions or omissions in connection with an affiliated company;
|
| p. |
actions or omissions in connection with the testing of products and services developed by Allot or in connection with the distribution, sale, license and use of such products and services, including clinical studies;
|
| q. |
actions or omissions in connection with the preparation and approval of financial or tax statements of Allot, including any action, consent or approval related to or arising from the foregoing, including engagement of or execution of
certificates for the benefit of third parties related to the financial statements;
|
| r. |
management of Allot’s bank accounts, including money management, foreign currency deposits, securities, loans and credit facilities, credit cards, bank guarantees, letters of credit, consultation agreements concerning investments
including with portfolio managers, hedging transactions, options, futures, and the like;
|
| s. |
actions or omissions taken pursuant to or in accordance with the policies and procedures of Allot, whether such policies and procedures are published or not;
|
| t. |
representations and warranties made in good faith in connection with the business of Allot;
|
| u. |
any claim or demand made by any lenders or other creditors or for monies borrowed by, or other indebtedness of Allot;
|
| v. |
any claim or demand made directly or indirectly in connection with complete or partial failure by Allot, or its respective directors, officers and employees, to pay, report, keep applicable records or otherwise, any state, municipal or
foreign taxes or other mandatory payments of any nature whatsoever, including income, sales, use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock,
social security, unemployment, disability, payroll or employee withholding or other withholding, including any interest, penalty or addition thereto, whether disputed or not;
|
| w. |
claims in connection with laws and regulations, including violations of laws and regulations requiring Allot to obtain regulatory and governmental licenses, permits and authorizations, laws related to any governmental grants in any
jurisdiction and laws regarding invasion of privacy, including with respect to databases, AI and laws and regulations in regard of slander;
|
| x. |
Any administrative, regulatory, judicial, civil or criminal, actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance, violation or breaches alleging
potential responsibility, liability, loss or damage (including potential responsibility or liability for costs of enforcement, investigation, cleanup, governmental response, removal or remediation, property damage or penalties, or for
contribution, indemnification, cost recovery, compensation or injunctive relief), whether alleged or claimed by customers, consumers, regulators, shareholders or others, arising out of, based on or related to: (a) cyber security,
cyber-attacks, data loss or breaches, unauthorized access to databases and use or disclosure of information contained therein, not preventing or detecting the breach or failing to otherwise disclose or respond to the breach;
(b) circumstances forming the basis of any violation of any law, permit, license, registration or other authorization required under applicable law governing data security, data protection, network security, information systems, privacy or
any cyber environment (including, users, networks, devices, software, processes, information systems, databases, information in storage or transit, applications, services, and systems that can be connected directly or indirectly to
networks); (c) failure to implement a reporting system or control, or failure to monitor or oversee the operation of such a system; (d) data destruction, extortion, theft, hacking, and denial of service attacks; losses or liabilities to
others caused by errors and omissions, failure to safeguard data or defamation; or (e) security-audit, post-incident public relations and investigative expenses, criminal reward funds, data breach/privacy crisis management (including,
management of an incident, investigation, remediation, data subject notification, call management, credit checking for data subjects, legal costs, court attendance and regulatory fines), extortion liability (including, losses due to a
threat of extortion, professional fees related to dealing with the extortion), or network security liability (including, losses as a result of denial of access, costs related to data on third-parties and costs related to the theft of data
on third-party systems);
|
| y. |
claims by any third party suffering any personal injury or any property damage to business or personal property through any act or omission attributed to Allot or its products or services, or its employees, agents or other persons acting
or allegedly acting on their behalf, including failure to make proper safety arrangements for Allot or its employees and liabilities arising from any accidental or continuous damage or harm to Allot’s employees, its contractors, its guests
and visitors as a result of an accidental or continuous event, or employment conditions, permanent or temporary, in Allot’s offices;
|
| z. |
claims relating to participation or non-participation at Board (including committees of the Board) meetings, or bona fide expression of opinion or voting or abstention from voting at such Board meetings including, in each case, any
committee thereof, as well as expression of any opinion publicly in connection with service as an Office Holder;
|
| aa. |
violations of or failure to comply with securities laws, and any regulations or other rules promulgated thereunder, of any jurisdiction, including claims under the U.S. Securities Act of 1933, as amended, or the U.S. Securities Exchange
Act of 1934, as amended, or under the Israeli Securities Law, 5728-1968, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange disclosure or other rules and any other claims relating to
relationships with investors, debt holders, shareholders, optionholders, holders of any other equity or debt instrument of Allot, and otherwise with the investment community (including any such claims relating to merger, change in control,
issuances of securities, restructuring, spin out, spin off, divestiture, recapitalization or any other transaction relating to the corporate structure or organization of Allot); claims relating to or arising out of financing arrangements,
any breach of financial covenants or other obligations towards investors, lenders or debt holders, class actions, violations of laws requiring Allot to obtain regulatory and governmental licenses, permits and authorizations in any
jurisdiction, including in connection with disclosure, offering or other transaction related documents; actions taken in connection with the issuance, purchase, holding or disposition of any type of securities of Allot, including the grant
of options, warrants or other rights to purchase any of the same or any offering of Allot’s securities (whether on behalf of Allot or on behalf of any holders of securities of Allot) to private investors, underwriters, resellers or to the
public, and listing of such securities, or the offer by Allot to purchase securities from the public or from private investors or other holders, and any undertakings, representations, warranties and other obligations related to any of the
foregoing or to Allot’s status as a public company or as an issuer of securities;
|
| bb. |
any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental or regulatory entity
or authority or any other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable to Allot or any of its businesses, assets or operations, or the terms
and conditions of any operating certificate or licensing agreement;
|
| cc. |
Liabilities arising in connection with development of any products or services developed, distributed, rendered, sold, provided, licensed or marketed by Allot, and any actions or omission in connection with the distribution, provision,
sale, marketing, license or use of such products or services, including without limitation in connection with professional liability and product liability claims;
|
| dd. |
Liabilities arising in connection with the conduct of clinical trials, testing, development or manufacturing of any products or services developed, distributed, rendered, sold, provided, licensed or marketed by Allot, and any actions in
connection with the distribution, provision, sale, marketing, license or use of such products or services, including without limitation in connection with professional liability and product liability claims; and
|
| ee. |
Any claim or demand not expressly covered by any of the categories of events described above, which, pursuant to any applicable law, an office holder of Allot may reasonably be held liable to any government or agency thereof, or any
person or entity, in connection with actions taken by such office holder in such capacity.
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 1. |
TO APPROVE AN AMENDMENT TO THE COMPANY’S ARTICLES OF ASSOCIATION, EFFECTIVE IMMEDIATELY UPON THE APPROVAL OF THIS PROPOSAL 1, TO PROVIDE FOR THE ELIMINATION OF THE DIFFERENT CLASSES OF MEMBERS OF THE BOARD OF DIRECTORS OF THE COMPANY (THE “BOARD”), SO THAT AFTER COMPLETION OF THEIR CURRENT TERM, THE TERM OF EACH DIRECTOR WHO IS ELECTED OR REELECTED AT OR AFTER THE ANNUAL MEETING SHALL BE ONE YEAR (OTHER THAN OUTSIDE DIRECTORS, AS DEFINED IN THE ISRAEL COMPANIES LAW, 5759-1999, AS AMENDED (THE “ISRAEL COMPANIES LAW”), WHO SHALL CONTINUE TO SERVE FOR FIXED THREE-YEAR TERMS IN ACCORDANCE WITH THE ISRAEL COMPANIES LAW). |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 2. |
TO REELECT NADAV ZOHAR AS A CLASS I DIRECTOR, TO SERVE UNTIL THE 2028 ANNUAL MEETING OF SHAREHOLDERS (OR, IF PROPOSAL 1 IS APPROVED, TO SERVE UNTIL THE 2026 ANNUAL MEETING OF SHAREHOLDERS), AND UNTIL HIS SUCCESSOR HAS BEEN DULY ELECTED AND QUALIFIED, OR UNTIL HIS OFFICE IS VACATED IN ACCORDANCE WITH THE COMPANY’S ARTICLES OF ASSOCIATION OR THE ISRAEL COMPANIES LAW. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 3. |
TO REELECT CYNTHIA L. PAUL AS A CLASS I DIRECTOR, TO SERVE UNTIL THE 2028 ANNUAL MEETING OF SHAREHOLDERS (OR, IF PROPOSAL 1 IS APPROVED, TO SERVE UNTIL THE 2026 ANNUAL MEETING OF SHAREHOLDERS), AND UNTIL HER SUCCESSOR HAS BEEN DULY ELECTED AND QUALIFIED, OR UNTIL HER OFFICE IS VACATED IN ACCORDANCE WITH THE COMPANY’S ARTICLES OF ASSOCIATION OR THE ISRAEL COMPANIES LAW. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 4. |
TO REELECT STEVEN LEVY AS AN OUTSIDE DIRECTOR OF THE COMPANY, TO SERVE FOR A TERM OF THREE YEARS COMMENCING AS OF THE ANNUAL MEETING, OR UNTIL HIS OFFICE IS VACATED IN ACCORDANCE WITH THE COMPANY’S ARTICLES OF ASSOCIATION OR THE ISRAEL COMPANIES LAW. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 5. |
TO APPROVE THE EXISTING COMPENSATION POLICY FOR OFFICERS AND DIRECTORS OF THE COMPANY FOR THE YEARS 2026-2028. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 6. |
TO APPROVE AN AMENDMENT TO THE INDEMNIFICATION PROVISIONS OF THE COMPANY’S ARTICLES OF ASSOCIATION. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 7. |
TO APPROVE AN AMENDED AND RESTATED INDEMNIFICATION AGREEMENT TO BE ENTERED INTO WITH EACH OF THE COMPANY’S DIRECTORS. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 8. |
TO APPROVE AN AMENDED AND RESTATED INDEMNIFICATION AGREEMENT TO BE ENTERED INTO WITH THE COMPANY’S CHIEF EXECUTIVE OFFICER. |
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
FOR
|
AGAINST | ABSTAIN |
| 9. |
TO APPROVE THE REAPPOINTMENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025 AND UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS, AND TO AUTHORIZE THE BOARD, UPON RECOMMENDATION OF THE AUDIT COMMITTEE, TO FIX THE REMUNERATION OF SAID INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. |
|
☐ | ☐ | ☐ |
|
The undersigned acknowledges receipt of the Notice of the Annual Meeting of Shareholders and Proxy Statement, dated November 12, 2025.
|
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the
account may not be submitted via this method. ☐
|
The proxy will be voted as specified. If a choice is not specified, this proxy will be voted “FOR” all proposals and in the discretion of the proxies with respect to all
other matters which may properly come before the meeting and any and all adjournments thereof.
IMPORTANT INSTRUCTION (PERSONAL INTEREST): By executing this proxy card, you are deemed to certify that you ARE NOT a controlling shareholder and DO NOT have a personal
interest in Proposals 4, 5 OR 8. In particular, every Allot shareholder voting by means of this proxy card, or via a voting instruction form, internet voting or telephone, will be deemed to confirm that he/she/it IS NOT a controlling
shareholder and DOES NOT have a personal interest in Proposals 4, 5 or 8. If you are a controlling shareholder or have a personal interest in Proposals 4, 5 or 8, please contact the Company’s General Counsel for guidance at +972-9-761-9200;
if you hold your shares in “street name,” you may also contact the representative managing your account, who should contact us on your behalf.
|
| Signature of Shareholder |
|
Date |
|
Signature of Shareholder |
|
Date |
|
Note: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as
executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please
sign in partnership name by authorized person.
|